Purchase Order 75D30124P19829
Award Date
9/30/24
Potential Completion Date
4/22/25
Potential Value
$50K
Federal Agency
CDC Pittsburgh
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $164,700.00 firm fixed-price purchase order is for monoclonal antibodies and plasmids services, with a completion date of June 14, 2026. The contract does not have a set-aside designation. Genscript is a key supplier of...
This federal contract award is for $17,568 to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS). The contract is for monoclonal antibodies and plasmids services to support biomedical research and public health initiatives. While the contract does not have a set-aside designation, Genscript has received other prime and...
This is a $164,700 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support critical research initiatives, with a period of performance through June 15, 2026. While the contract does not have a set-aside...
This firm fixed-price purchase order, valued at $16,215, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support NIAID's biomedical research and public health initiatives. Genscript, a for-profit organization, has received numerous prime...
This $8,435.16 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health, to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract is for antibody production services, with a completion date of June 15, 2018. Genscript specializes in providing a range of biomedical research and public health products and services to...
This contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, provides Genscript USA Inc. with $137,250.00 to deliver monoclonal antibodies and plasmid services. The firm-fixed price purchase order has an ultimate completion date of August 31, 2025. Genscript USA Inc. is a biotechnology company in Piscataway, New Jersey that specializes in molecular biology products and services for federal agencies....
This federal contract was awarded by the Plains Area division of a civilian federal agency to Genscript USA Inc., a biotechnology company based in New Jersey. The $3,458.11 firm fixed-price purchase order is for protein expression and purification services. The contract does not have a set-aside designation. Genscript has received numerous prime and subcontract awards from federal agencies like the Department of Health and Human Services (including the National Institutes of Health, Centers...
This is a $97,722.00 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support NIAID's research initiatives, with a completion date of September 19, 2025. This contract is not designated as a set-aside....
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $3,800.00, is for custom monoclonal antibody production services to support NIAID's biomedical research and public health initiatives. This contract does not have a set-aside designation. Genscript...
Genscript USA Inc. was awarded a $90,340 purchase order by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania. Under the terms of the contract, Genscript will provide bulk antibody production services in support of the CDC's CVV (Comparative Vaccine Vector) program. Performance will take place at Genscript's facility in Chamblee, Georgia over the course of one year, from September 2022 through September 2023. The contract has a firm fixed price and no set-aside...